2 products were found matching "151823-14-2"!

No results were found for the filter!
Sapacitabine
Sapacitabine

Item number: Cay27321-10

Sapacitabine is a prodrug form of the nucleoside derivative CNDAC (Cay-40672). In vivo, sapacitabine (5 and 15 mg/kg) reduces tumor volume in an MV4-11 mouse xenograft model when administered alone or in combination with the histone deacetylase (HDAC) inhibitor SAHA (vorinostat, Cay-10009929).Formal Name:...
Keywords: CS 682, CYC-682, N-[1-(2-cyano-2-deoxy-b-D-arabinofuranosyl)-1,2-dihydro-2-oxo-4-pyrimidinyl]-hexadecanamide
Application: Nucleoside derivative CNDAC prodrug form, antineoplastic, antimetabolite
CAS 151823-14-2
MW: 490.6 D
From 107.00€ *
Review
Sapacitabine
Sapacitabine

Item number: TGM-TQ0245-2mg

Description: Sapacitabine (CS682) is an orally available nucleoside analog precursor compound with potential anti-tumor activity for the study of acute myeloid leukemia. Target: Nucleoside Antimetabolite/Analog. Smiles: CCCCCCCCCC CCCCCC(=O)Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2C#N)c(=O)n1. References: Serova M,...
Keywords: CYC682, CS682
Application: Antineoplastic, Antimetabolite
CAS 151823-14-2
MW: 490.64 D
37.00€ *
Review